{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:48:05Z","timestamp":1784951285914,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.autrev.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T16:23:18Z","timestamp":1487002998000},"page":"352-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence"],"prefix":"10.1016","volume":"16","author":[{"given":"Gabriela","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Briones-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Cruz-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar I.","family":"Fl\u00f3rez-Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.02.004_bb0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/asheducation-2015.1.53","article-title":"The antiphospholipid syndrome: still an enigma","volume":"2015","author":"Chaturvedi","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.autrev.2017.02.004_bb0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0961203315617538","article-title":"Patients with antiphosholipid syndrome and thrombotic recurrences: a real world observation (the Piedmont cohort study)","volume":"25","author":"Bazzan","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.02.004_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1157\/13115821","article-title":"Anticoagulation treatment withdrawal in primary antiphospholipid syndrome when anticardiolipin antibodies become negative","volume":"208","author":"Criado-Garc\u00eda","year":"2008","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.autrev.2017.02.004_bb0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrrheum.2015.88","article-title":"Current treatment of antiphospholipid syndrome: lights and shadows","volume":"11","author":"Espinosa","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.004_bb0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12026-013-8407-x","article-title":"Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative","volume":"56","author":"Coloma Baz\u00e1n","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2017.02.004_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2017.02.004_bb0035","doi-asserted-by":"crossref","first-page":"621270","DOI":"10.1155\/2014\/621270","article-title":"Cardiovascular risk factors in the antiphospholipid syndrome","volume":"2014","author":"da Silva","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2017.02.004_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2010.10.004","article-title":"Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients","volume":"10","author":"Medina","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.004_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0961203309360545","article-title":"Non-criteria manifestations of antiphospholipid syndrome","volume":"19","author":"Erkan","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.02.004_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11926-015-0502-7","article-title":"Difficult clinical situations in the antiphospholipid syndrome","volume":"17","author":"Rosa","year":"2015","journal-title":"Curr Rheumatol Rep"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T16:36:14Z","timestamp":1568824574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1568997217300447"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}